SynthesisProceedings (Baylor University. Medical Center)2026

Efficacy and safety of durvalumab with or without tremelimumab in the treatment of metastatic non-small cell lung cancer: a meta-analysis of randomized controlled trials.

Ursula Medeiros Araujo de Matos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.